Macy’s was kicked out of the S & P 500 with a market value of only 1/15 of its peak.
Big company
Macy ’s was kicked out of the S & P 500, with a market value of only 1/15 of its peak period
On March 31st local time, the international rating agency and index supplier Standard & Poor’s removed Macy’s from the S & P 500 Index and placed the latter in the S & P 600. In this regard, Standard & Poor’s said that since last year, Macy’s operating conditions have deteriorated rapidly, with operating cash flow of 1.6 billion, the lowest in years, so Macy’s market value is more representative of small-cap market space.
On April 1, Hong Kong stocks of biomedical company Cinda Bio-B (01801.HK) rose as much as 3.67% in early trading. On the same day, Guotai Junan released a performance review report saying that its core product sales were in line with market expectations, maintained a “cautious increase” rating, and raised its target price to HK $ 34.5. On March 31, CITIC Construction Investment released a research report stating that Daboshu had excellent commercialization results and gave Cinda Bio a “Buy” rating with a target price of HK $ 41.7.
With the breaking of the online payment of Internet medical insurance, the scale of the Internet medical market will also expand accordingly. On April 1, Hong Kong stocks of Doctor Ping An Good (01833.HK) closed up 2.28% against the market and reported at HK $ 73.95 / share, with a turnover of HK $ 368 million throughout the day. At present, the latest market value of Ping An Good Doctor is HK $ 78.926 billion.
Meituan (03690.HK) ‘s latest performance report exceeded market expectations. In Q4 of 2019, Meituan’s total revenue was 28.2 billion yuan, an increase of 42.2% year-on-year, and adjusted net profit was 2.27 billion yuan, which was a year-on-year loss. Extending to the whole of 2019, the overall financial status of Meituan has been continuously improved, and it has achieved profit for three consecutive quarters.
Baidu intends to issue USDBonds to meet investment needs in the coming year
It is learned that on April 1, Beijing time, Baidu submitted documents to the US Securities and Exchange Commission (SEC), announcing that it intends to issue bonds, and the underwriters are Goldman Sachs and Bank of America. Baidu claims that the proceeds from the bond issuance will be used to repay some of its existing debt and daily corporate use. Baidu did not disclose the bond size and interest rate in the document.
Investment and financing
In the first quarter of 2020, the Hong Kong Hang Seng Index fluctuated steadily, and the performance of new stocks showed differentiation. On March 31, KPMG released its “Review of the First Quarter of 2020: IPO and Other Capital Market Development Trends.” The report shows that in the first quarter, the Hong Kong Main Board recorded a total of 35 IPOs, raising a total of 14 billion Hong Kong dollars. The number of completed IPOs on the Main Board was the highest in the same period in the past five years, but the number of IPOs raised over HK $ 1 billion decreased from eight in the same period in 2019 to three in the current quarter, resulting in a decrease of approximately 33% year-on-year.
The perfect diary is back with money, only six months from the previous round. On April 1, according to The Information, the beauty brand Perfect Diary has received a new round of financing, amounting to $ 100 million, led by Tiger Global Management Corporation, Houpu Management Investment Company, Boyu Capital participated in the investment.
On March 31, Aiyouyou Co., Ltd. (hereinafter referred to as “Aiyouyou”) again submitted a listing application to the main board of the Hong Kong Stock Exchange, with CITIC Construction Investment International as its sole sponsor.
April 1, medicineMing Bio (02269.HK) released the morning Announcement , announcing its controlling shareholder WuXi Biologics Holdings Limited (hereinafter referred to as “Biologics Holdings”) entered into a transaction agreement with Morgan Stanley on March 31 to place shares at a price of HK $ 96.80 per share to parties independent of and not connected with the company by Biologics Holdings The company holds 48 million existing shares and intends to raise financing of 4.646 billion Hong Kong dollars from the placing.
Yingke repurchased 614,000 shares on April 1, costing 613,000 Hong Kong dollars
It is learned that Yingke announced that the company spent 613,000 Hong Kong dollars on April 1 to repurchase 614,000 shares, and the repurchase price was 0.99-1.01 Hong Kong dollars per share.
According to the announcement, Sanqi Mutual Entertainment announced that it plans to raise no more than 4.5 billion yuan for online game development and operation construction projects, 5G cloud game platform construction projects, and Guangzhou headquarters building construction projects.
New product
Recently, the international version of Tencent’s “New Crown Pneumonia Self-Screening Tool” (COVID-19 Symptoms Self-checker) has been officially launched to global users on the Tencent “Together We Can” global war “epidemic” information platform. The tool uses a full English interface, which allows overseas users to better assess personal risks through intelligent dialogue and AI engines. (Tencent Technology)